NCT Number: NCT00223028
Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation
To investigate in renal transplant recipients the potential drug intreaction between Sirolimus, Mycophenolt Mofetil and Fluvastatin
All patient enrolled in this PKI-Study had no changes in the therapy before or because of the study. Only patients without changes more than 4 weeks before startin the study were included
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- renal transplant patients (18 - 65 years, inclusive)
- cadaver and living renal transplants(1. Ntx, 2. Ntx)
- Immunsuppression: sirolimus with or without Mycophenolat Mofetil und and fluvastatin Fluvastatin for a minimum of three months
- writen informt consent by the patient
Exclusion criteria
- contraindications for statins
- pregnancy or lactating
- elevated liver or muscle encymes (> 2x up to normal values: AST, ALT, bilirubine, CPK)
Treatment and study plan
Sponsors and collaborators
Lead sponsor
University Hospital Schleswig-Holstein
Other
Registry information
Important dates
- Study start
- 2005
- Study completion
- 2005
- First posted
- Sep 22, 2005
- Registry last updated
- Oct 28, 2005
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Belatacept Early Steroid Withdrawal Trial
NCT01729494
Renal Transplantation
San Francisco, California, United States
View Trial DetailsQuantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients
NCT04774575
Renal Transplantation
Nantes, France
View Trial DetailsStudy of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients
NCT03114826
Adenocarcinoma, Carcinoma
Amiens, Picardie, France
View Trial DetailsRenal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
NCT00337051
Acute Kidney Injury, Chronic Disease
Bordeaux, France
View Trial Details